Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Cowen 43rd Annual Health Care Conference March 6, 2023 12:50 PM ET Company Participants Marion McCourt - EVP of Commercial Ryan Crowe - Vice President & Head of IR Conference Call Participants Tyler Van Buren - Cowen Tyler Van Buren Good afternoon, everyone. I'm Tyler Van Buren here, Senior Biotech Analyst at TD Cowen. Thank you very much for joining us for TD Cowen's 43rd Annual Healthcare Conference. For our next session, very pleased to have a fireside chat w ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) SVB Securities Global Biopharma Conference February 14, 2023 9:20 AM ET Company Participants Ryan Crowe - VP, IR Izzy Lowy - SVP of Clinical Development for Oncology Andres Sirulnik - SVP, Translational & Clinical Sciences, Hematology Conference Call Participants David Risinger - SVB Securities David Risinger So good morning, everybody, and thank you for joining our session with Regeneron. My name is Dave Risinger. I'm responsible for diversified biopharmaceutic ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________ to __________ Commission File Number: 000-19034 REGENERON PHARMACEUTICALS, INC. (Exact name of registrant as specified in its charter) New York 13-34446 ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2022 Earnings Conference Call February 3, 2023 8:30 AM ET Company Participants Ryan Crowe - Vice President, Investor Relations Leonard Schleifer - Co-Founder, President and Chief Executive Officer George Yancopoulos - Co-Founder, President and Chief Scientific Officer Marion McCourt - Executive Vice President and Head, Commercial Bob Landry - Executive Vice President and Chief Financial Officer Conference Call Participants Tyler Van Buren - Cowen Matthew Harr ...

Regeneron Corporate Presentation F e b r u a r y 2 0 2 3 This non-promotional presentation contains investigational data as well as forward-looking statements; actual results may vary materially. 2 Note regarding forward-looking statements and non-GAAP financial measures This presentation includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company"), and actual events or results ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) 41st Annual J.P. Morgan Healthcare Conference January 9, 2023 12:00 PM ET Company Participants Leonard Schleifer - President and CEO George Yancopoulos - President and Chief Scientific Officer Marion McCourt - EVP and Head of Commercial Conference Call Participants Chris Schott - JPMorgan Chris Schott Good morning, everybody. I'm Chris Schott, diversified biopharma analyst at JPMorgan, and it's my pleasure to be introducing Regeneron this morning. Representing t ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Piper Sandler 34th Annual Healthcare Conference Call November 30, 2022 8:00 AM ET Company Participants Ryan Crowe - Vice President of Investor Relations Robert Landry - Executive Vice President & Chief Financial Officer Conference Call Participants Chris Raymond - Piper Sandler Chris Raymond Okay. Let's go ahead and get started. Thanks everybody for attending Day 2 of the 34th Annual Piper Sandler Healthcare Conference. My name is Chris Raymond. I'm one of the b ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) 5th Annual Evercore ISI HealthCONx Conference November 29, 2022 11:45 AM ET Company Participants Ryan Crowe - Vice President, Investor Relations John Lin - Senior Vice President, Immuno-Oncology & Head, Bi-Specifics Neil Stahl - Executive Vice President, Research & Development Conference Call Participants Josh Schimmer - Evercore ISI Josh Schimmer All right. Welcome, everyone. This is Josh Schimmer from Evercore ISI biotech team. Pleased to welcome. From Regener ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Jefferies London Healthcare Conference November 16, 2022 10:15 AM ET Company Participants Ryan Crowe - VP, IR Robert Landry - EVP, Finance & CFO Conference Call Participants Akash Tewari - Jefferies Akash Tewari All right. Well, good afternoon. Day two of the London Healthcare Conference. My name is Akash Tewari. I'm one of the therapeutic analysts here. I hope you guys are all enjoying yourself. I'll tell you, it's wonderful to see everyone back, it really is. ...